Omid R. Hariri

Omid R. Hariri

Auto-generated profile, based on publicly available information

Omid R. Hariri

Department of Neurosurgery, Southern California Permanente Medical Group, Anaheim, CA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2018 in Journal of Neuroimaging
Verified
Journal Article
Closed access
PDF file
AZAtif Zafar
Atif Zafar
SQSyed A. Quadri
Syed A. Quadri
MFMudassir Farooqui
Mudassir Farooqui
SGSantiago Ortega Gutierrez
Santiago Ortega Gutierrez
OHOmid R. Hariri
Omid R. Hariri
HYHoward Yonas
Howard Yonas

15 November 2023 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
ASArman Sourani
Arman Sourani
NVNoushin Vahdat
Noushin Vahdat
CSColin Son
Colin Son
OHOmid R Hariri
Omid R Hariri
MRMajid Rezvani
Majid Rezvani
SMSadegh Baradaran Mahdavi
Sadegh Baradaran Mahdavi

8 August 2024 in Cancers
Verified
Journal Article
Open access
PDF file
RHRebecca Houston
Rebecca Houston
SDShivum Desai
Shivum Desai
ATAriel Takayanagi
Ariel Takayanagi
CTChristina Quynh Thu Tran
Christina Quynh Thu Tran
AMAli Mortezaei
Ali Mortezaei
OHOmid Hariri
Omid Hariri
Spinal metastases occur in up to 40% of patients with cancer. Of these cases, 10% become symptomatic. The reported incidence of spinal metastases has increased in recent years due to innovations in imaging modalities and oncological treatments. As the incidence of spinal metastases rises, so does the demand for improved treatments and treatment algorithms, which now emphasize greater multidisciplinary collaboration and are increasingly customized per patient. Uniquely, we discuss the potential clinical applications of AI and NGS in the treatment of spinal metastases. Material and Methods: A PubMed search for articles published from 2000 to 2023 regarding spinal metastases and artificial intelligence in healthcare was completed. After screening for relevance, the key findings from each study were summarized in this update. Results: This review summarizes the evidence from studies reporting on treatment modalities for spinal metastases, including minimally invasive surgery (MIS), external beam radiation therapy (EBRT), stereotactic radiosurgery (SRS), CFR-PEEK instrumentation, radiofrequency ablation (RFA), next-generation sequencing (NGS), artificial intelligence, and predictive models.

22 October 2024 in Spine Deformity
Verified
Journal Article
Closed access
PDF file
MRMajid Rezvani
Majid Rezvani
MMMohammadreza Mehrabanian
Mohammadreza Mehrabanian
OHOmid R. Hariri
Omid R. Hariri
CSColin Son
Colin Son
NVNoushin Vahdat
Noushin Vahdat
ASArman Sourani
Arman Sourani

20 July 2026 in Spine
Verified
Journal Article
Closed access
AYAlem Yacob
Alem Yacob
HPHeather Prentice
Heather Prentice
APAmit Piple
Amit Piple
JHJessica Harris
Jessica Harris
CKCalvin C. Kuo
Calvin C. Kuo
ETEhsan Tabaraee
Ehsan Tabaraee
Study Design.: Retrospective Cohort Study Objective.: To compare multilevel posterior cervical laminoplasty (PCL) versus multilevel posterior cervical laminectomy and fusion (PLF) in a US-based cohort, hypothesizing outcomes would differ by approach. Summary of Background Data.: Posterior approaches to the cervical spine are versatile and comprehensive means of addressing operative pathology. Methods.: Using data from a US-based healthcare system’s multicenter spine registry, adult patients who underwent primary posterior only cervical surgeries involving ≥2 levels between C3-T2 were identified (2009-2023). Operative adjacent segment disease (ASD) was evaluated longitudinally. Secondary outcomes included operative non-union, reoperation for any reason, and mortality, also evaluated longitudinally, as well as 90-day emergency department (ED) visit and 90-day readmission. Multivariable Cox proportional hazards for longitudinal outcomes and logistic regression for binary outcomes were used with adjustment for covariates and operating surgeon. Results.: The study included 4,412 patients, 1,294 (29.3%) with PCL. Mean age (64.2 vs 65.2 y), gender (36.9% vs 41.7% female), and BMI (29.0 vs 29.1 kg/m 2 ) were similar between PCL and PLF groups, respectively; while imbalance was observed in the distribution of myelopathy diagnosis, spondylolisthesis diagnosis, number of levels involved, and operative time. In adjusted analyses, PCL was associated with a lower risk of operative ASD (hazard ratio [HR]=0.42, 95% confidence interval [CI]=0.22-0.82) compared to PLF. A lower risk for all-cause reoperation (HR=0.51, 95% CI=0.33-0.79) was also observed for PCL compared to PLF, while no differences were observed in mortality (HR=0.81, 95% CI=0.62-1.06), 90-day ED visits (odds ratio [OR]=0.84, 95% CI=0.67-1.05), or 90-day readmissions (OR=0.84, 95% CI=0.63-1.11). Conclusions.: In this large cohort, multilevel PCL was associated with a lower risk of operative ASD and overall reoperation compared to PLF. Further studies should explore why PLF is selected at more than twice the rate of PCL despite the higher reoperation risks observed in the present cohort.